What's in Ibis Reproductive Health's pipeline?

Ibis Reproductive Health has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ibis Reproductive Health's portfolio?

Top competitors by shared drug class: AbbVie, Ain Shams University, Allergan, Bnai Zion Medical Center, Ocuwize LTD.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ibis-reproductive-health.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ibis Reproductive Health — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ibis Reproductive Health pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Misoprostol-only medication abortion regimen	Misoprostol-only medication abortion regimen	marketed	Prostaglandin analog	Prostaglandin F receptor (FP receptor)	Reproductive Health

Therapeutic area mix

Reproductive Health · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Ain Shams University · 1 shared drug class
Allergan · 1 shared drug class
Bnai Zion Medical Center · 1 shared drug class
Ocuwize LTD · 1 shared drug class
Shaare Zedek Medical Center · 1 shared drug class
University Medical Centre Maribor · 1 shared drug class
University of North Carolina, Chapel Hill · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ibis Reproductive Health:

Cite this brief

Drug Landscape (2026). Ibis Reproductive Health — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ibis-reproductive-health. Accessed 2026-05-17.